Hippo pathway in organ size control, tissue homeostasis, and cancer

Cited by (1,005)

Items 701–800 of 1,005

1. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs
   Uttam Sharma, Hardeep Singh Tuli, Vivek Uttam, Renuka Choudhary, Bunty Sharma, Ujjawal Sharma, Hridayesh Prakash, Aklank Jain · 2022 · Pharmacological Research
2. Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti‐PD ‐1 efficacy
   Qing Peng, Shenghao Li, Xinli Shi, Yinglin Guo, Liyuan Hao, Zhiqin Zhang, Jingmin Ji, Yanmeng Zhao, Caige Li, Yu Xue et al. · 2022 · Phytotherapy Research
3. The role of Hippo pathway in ovarian development
   Mengdi Zhu, Menghao Xu, Jinmin Zhang, Cuihong Zheng · 2023 · Frontiers in Physiology
4. The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis
   Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han et al. · 2024 · Oncogene
5. Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways
   Dequan Liu, Xiangyu Che, Guangzhen Wu · 2024 · Biomarker Research
6. Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics
   Subhadeep Das, Shayak Samaddar · 2025 · Cancers
7. Expression of Hippo signaling pathway components in Hu sheep male reproductive tract and spermatozoa
   Guomin Zhang, Tingting Zhang, Shiyu An, M.A. El-Samahy, Hua Yang, Yongjie Wan, Fanxing Meng, Shen‐Hua Xiao, Feng Wang, Zhihai Lei · 2018 · Theriogenology
8. Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders?
   Jens Stepan, Elmira A. Anderzhanova, Nils C. Gassen · 2018 · Frontiers in Psychiatry
9. LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma
   Chengyong Guo, Chaohui Liang, Jipeng Yang, Hongchao Hu, Bo Fan, Xin Liu · 2019 · Oncology Reports
10. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells
    Yu Chang, Xiaorui Fu, Meng Cui, Wei‐Ming Li, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xudong Zhang, Zhaoming Li et al. · 2019 · Cancer Medicine
11. MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
    Jimyung Seo, Min Hwan Kim, Hyowon Hong, Hyunsoo Cho, Seongyeol Park, Sang Kyum Kim, Joon Kim · 2019 · Cancer Research
12. Awakening the regenerative potential of the mammalian retina
    James F. Martin, Ross A. Poché · 2019 · Development
13. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer
    Xiaoli Wen, Jing Wan, Qizhi He, Mengfei Wang, Shuangdi Li, Mei Hua Jiang, Zhen Qian, Binya Liu, Wen Lu, Kai Wang et al. · 2020 · Signal Transduction and Targeted Therapy
14. Plant U‐box E3 ligases PUB25 and PUB26 control organ growth in Arabidopsis
    Jing Li, Yongxia Zhang, Zhong Gao, Xiumei Xu, Yanzhi Wang, Yaoxi Lin, Peiming Ye, Tengbo Huang · 2020 · New Phytologist
15. A Dynamic Role of Mastermind-Like 1: A Journey Through the Main (Path)ways Between Development and Cancer
    Sabrina Zema, Maria Pelullo, Francesca Nardozza, María Pía Felli, Isabella Screpanti, Diana Bellavia · 2020 · Frontiers in Cell and Developmental Biology
16. Kindlin-2 in Sertoli cells is essential for testis development and male fertility in mice
    Xiaochun Chi, Weiwei Luo, Jiagui Song, Bing Li, Tiantian Su, Miao Yu, Tianzhuo Wang, Zhenbin Wang, Cheng Liu, Zhen Li et al. · 2021 · Cell Death and Disease
17. Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis
    Yu Wang, Yuwen Zhu, Yuan Gu, Mingyue Ma, Yebin Wang, Sixian Qi, Yan Jun Zeng, Rui Zhu, Xueying Wang, Pengcheng Yu et al. · 2021 · Cell Reports
18. Identification, Culture and Targeting of Cancer Stem Cells
    Alejandro Herreros‐Pomares · 2022 · Life
19. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ
    Jianing Tang, Yongwen Luo, Xiao Dong Liang · 2022 · Cell Death and Disease
20. A nuclear receptor facilitates differentiation of human PSCs into more mature hepatocytes
    Haiting Ma, Esmée de Zwaan, Yang Eric Guo, Paloma Cejas, Prathapan Thiru, Martijn van de Bunt, Jacob Fuglsbjerg Jeppesen, Sudeepa Syamala, Alessandra Dall’Agnese, Brian J. Abraham et al. · 2022 · Cell stem cell
21. YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer
    Jie Shen, Qingwen Huang, Weiyi Jia, Shengjie Feng, Liang Liu, Xiaolan Li, Deding Tao, Daxing Xie · 2022 · Oncogene
22. DLG 5 suppresses breast cancer stem cell‐like characteristics to restore tamoxifen sensitivity by inhibiting TAZ expression
    Jie Liu, Juan Li, Pingping Li, Yina Jiang, He Chen, Ruiqi L. Wang, Fang Cao, Peijun Liu · 2018 · Journal of Cellular and Molecular Medicine
23. Protein phosphatase 2ACα gene knock-out results in cortical atrophy through activating hippo cascade in neuronal progenitor cells
    Liu, Bo, Sun, Li-Hua, Huang, Yan-Fei, Guo, Li-Jun, Luo, Li-Shu · 2018 · The International Journal of Biochemistry & Cell Biology
24. The critical role of the Hippo signaling pathway in kidney diseases
    Yu-Ting Sun, De Jin, Zi-Wei Zhang, Di Jin, Jiaojiao Xue, Li-Yun Duan, Yu-Qing Zhang, Xiao-Min Kang, Feng-Mei Lian · 2022 · Frontiers in Pharmacology
25. Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology
    Xin Chen, Xing Ji, Zhaobai Lao, Bin Pan, Yu Qian, Wanlei Yang · 2025 · Journal of Orthopaedic Translation
26. Role of Src Family Kinases in Regulation of Intestinal Epithelial Homeostasis
    Shinya Imada, Yoji Murata, Takenori Kotani, Masaki Hatano, Chunxiao Sun, Tasuku Konno, Jungha Park, Yasuaki Kitamura, Yasuyuki Saito, Hideki Ohdan et al. · 2016 · Molecular and Cellular Biology
27. Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK
    Peter Kubiniok, Hugo Lavoie, Marc Therrien, Pierre Thibault · 2017 · Molecular & Cellular Proteomics
28. YAP and WWTR1: New targets for skin cancer treatment
    Thomas Andl, Linli Zhou, KUN YU YANG, Ana Luisa Kadekaro, Yuhang Zhang · 2017 · Cancer Letters
29. A growing role for the Hippo signaling pathway in the heart
    Yu Zhang, Dominic P. Del Re · 2017 · Journal of Molecular Medicine
30. Research Models and Gene Augmentation Therapy for CRB1 Retinal Dystrophies
    Nanda Boon, Jan Wijnholds, Lucie P. Pellissier · 2020 · Frontiers in Neuroscience
31. NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output
    Md Imtiaz Khalil, Ishita Ghosh, Vibha Singh, Jing Chen, Haining Zhu, Arrigo De Benedetti · 2020 · Cancers
32. SOX9-transactived long non-coding RNA NEAT1 promotes the self-renewal of liver cancer stem cells through PKA/Hippo signaling
    Zhuo Cheng, Xijun Liang, Cheng Zhang, Ruoyu Wang, Tingting Wei, Beifang Ning, Elżbieta Poręba, Liang Li, Hongyang Wang, Jin Ding · 2021 · Signal Transduction and Targeted Therapy
33. α-Catenin levels determine direction of YAP/TAZ response to autophagy perturbation
    Mariana Pavel Tanasa, So Jung Park, Rebecca A. Frake, Sung Min Son, Marco M. Manni, Carla F. Bento, Maurizio Renna, Thomas Ricketts, Fiona M. Menzies, Radu Tanasa et al. · 2021 · Nature Communications
34. MINDY1 promotes bladder cancer progression by stabilizing YAP
    Yongwen Luo, Jun Zhou, Jianing Tang, Fengfang Zhou, Zhiwen He, Tongzu Liu, Tao Liu · 2021 · Cancer Cell International
35. HTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis
    Tiejun Zhao, Zhilong Wang, Jinyong Fang, Wenzhao Cheng, Yiling Zhang, Jinhua Huang, Lingling Xu, Hongwei Gou, Linghui Zeng, Zhigang Jin et al. · 2022 · Proceedings of the National Academy of Sciences
36. Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
    Yi Zhang, Fang Zhou, Jiaheng Guan, Lukun Zhou, Baoan Chen · 2023 · Biomolecules
37. miR-285– Yki/Mask double-negative feedback loop mediates blood–brain barrier integrity in Drosophila
    Dong Li, Yanling Liu, Chunli Pei, Peng Zhang, Linqing Pan, Jing Xiao, Songshu Meng, Zengqiang Yuan, Xiaolin Bi · 2017 · Proceedings of the National Academy of Sciences
38. Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer
    Yoshinori Matsuda, Shintaro Narita, Taketoshi Nara, Mingguo Huang, Hiromi Sato, Atsushi Koizumi, Sohei Kanda, Kazuyuki Numakura, Mitsuru Saito, Takamitsu Inoue et al. · 2020 · BMC Cancer
39. Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics
    Lawrence Wen Wu, Sung Joo Jang, Cameron Shapiro, Ladan Fazlollahi, Timothy Cragin Wang, Sandra W. Ryeom, Ryan H. Moy · 2024 · Targeted Oncology
40. Early rumen development in calves: Biological processes and nutritional strategies—A mini-review
    Morteza Hosseini Ghaffari, Harald Michael Hammon, Christian Koch · 2025 · JDS Communications
41. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions
    Liu Mei, Lianwen Yuan, Wei Shi, Shihao Fan, Chao Tang, Xueying Fan, Wanlei Yang, Yu Qian, Musaddique Hussain, Ximei Wu · 2016 · Cancer Letters
42. Emerging application of genomics-guided therapeutics in personalized lung cancer treatment
    Aubhishek Zaman, Trever Grant Bivona · 2018 · Annals of Translational Medicine
43. DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions
    Anello Marcello Poma, Vincenzo Condello, Maria Denaro, Liborio Torregrossa, Rossella Elisei, Paolo Vitti, Fulvio Basolo · 2019 · Oncotarget
44. Gambogic acid impairs tumor angiogenesis by targeting YAP/STAT3 signaling axis
    Li Wan, Qun Zhang, Sheng Wang, Yong Gao, Xiaofei Chen, Yang Zhao, Xiaoping Qian · 2019 · Phytotherapy Research
45. Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway
    Gaoran Xu, Jun-zhu Chen, Guorong Wang, Junhong Xiao, Ning Zhang, Yanyu Chen, Haoran Yu, Guangzhi Wang, Yongfu Zhao · 2020 · Molecular Therapy — Oncolytics
46. NEDD4L‐mediated Merlin ubiquitination facilitates Hippo pathway activation
    Yiju Wei, Patricia P. Yee, Zhijun Liu, Lei Zhang, Hui Guo, Haiyan Zheng, Benjamin Anderson, Melissa Gulley, Wei Li · 2020 · EMBO Reports
47. Phosphoinositide Signaling and Mechanotransduction in Cardiovascular Biology and Disease
    Amanda Krajnik, Joseph A. Brazzo, Kalyanaraman Vaidyanathan, Tuhin Das, Javier Redondo-Muñóz, Yongho Bae · 2020 · Frontiers in Cell and Developmental Biology
48. Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
    Salah-Eddine Lamhamedi-Cherradi, Sana Mohiuddin, Dhruva Kumar Mishra, Sandhya Krishnan, Alejandra Ruiz Velasco, Amelia M. Vetter, Kristi A. Pence, David C. McCall, Danh D. Truong, Branko Cuglievan et al. · 2021 · Cancer Gene Therapy
49. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo‐related genes in hepatocellular carcinoma
    Qingbo Pan, Fanbo Qin, Hanyu Yuan, Baoning He, Ni Yang, Yitong Zhang, Hong Ren, Yi Arial Zeng · 2021 · Cancer Medicine
50. A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition
    Cecilia Savorani, Matteo Malinverno, Roberta Seccia, Claudio Maderna, Monica Giannotta, Linda Terreran, Eleonora Mastrapasqua, Stefano Campaner, Elisabetta Dejana, Costanza Giampietro · 2021 · Journal of Cell Science
51. Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
    Yan Wang, Xiang Wang, Xu Wang, Di Wu, Ji Qi, Yu Zhang, Kai Wang, Ding Zhou, Qingming Meng, Er Nie et al. · 2021 · Journal of Cellular and Molecular Medicine
52. Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats
    Raphaëlle Corremans, Ellen Neven, Stuart R. Maudsley, Hanne Leysen, Marc E. De Broe, Patrick C. D’Haese, Benjamin A. Vervaet, Anja Verhulst · 2022 · Kidney International
53. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype
    Tingting Yu, Lan Yao, Hua Yin, Yao Teng, Mei Hong, Qiuling Wu · 2022 · International Journal of Biological Sciences
54. Insights Into the Properties, Biological Functions, and Regulation of USP21
    Tao An, Yanting Lu, Yan Lei Xu, Jingjing Hou · 2022 · Frontiers in Pharmacology
55. THY1-mediated mechanisms converge to drive YAP activation in skin homeostasis and repair
    Egor Sedov, Elle Koren, Sucheta Chopra, Roi Ankawa, Yahav Yosefzon, Marianna Yusupova, Lucien E. Weiss, Adnan Mahly, Arad Soffer, Alona Feldman et al. · 2022 · Nature Cell Biology
56. TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities
    Keith C. Garcia, Anne‐Claude Gingras, Kieran F. Harvey, Munir R. Tanas · 2022 · Trends in cancer
57. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway
    Dan Hu, Ruo Yu Meng, Thi Van Nguyen, Ok Hee Chai, Byung S. Park, Ju‐Seog Lee, Soo‐Jeong Kim · 2022 · Molecular Medicine Reports
58. Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy
    Fedir M. Bokhovchuk, Yannick Mesrouze, Aude Izaac, Marco Meyerhofer, Catherine Zimmermann, Patrizia Fontana, Tobias Schmelzle, Dirk Erdmann, Pascal Furet, Joerg A. Kallen et al. · 2019 · FEBS Journal
59. EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation
    Lizhi Pang, Harshit Shah, Hongzhi Wang, Dan Shu, Steven Y. Qian, Venkatachalem Sathish · 2020 · Molecular Therapy — Nucleic Acids
60. Ca2+ signaling and the Hippo pathway: Intersections in cellular regulation
    Samar Sayedyahossein, Louise Thines, David B. Sacks · 2023 · Cellular Signalling
61. When You Come to a Fork in the Road, Take It: Wnt Signaling Activates Multiple Pathways through the APC/Axin/GSK-3 Complex
    Chenchen Li, Emma Elizabeth Furth, Anil K. Rustgi, Peter S. Klein · 2023 · Cells
62. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases
    Thibault Kervarrec, Danna Westphal, Daniel Pissaloux, Mélanie Legrand, Franck Tirode, Anne Neuhart, Françoise Drouot, Jürgen Christian Becker, Nicolas Macagno, Alice Seris et al. · 2024 · Histopathology
63. Precise targeting of transcriptional co-activators YAP/TAZ annihilates chemoresistant brCSCs by alteration of their mitochondrial homeostasis
    Priyanka Dey Talukdar, Kunal Pramanik, Priya Gatti, Pritha Mukherjee, Deepshikha Ghosh, Himansu Roy, Marc Germain, Urmi Chatterji · 2025 · Signal Transduction and Targeted Therapy
64. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma
    Jun Liu, Xinhui Zhao, Ke Wang, Xiang Zhang, Yanping Yu, Yongzhi Lv, Shun Zhang, Long Zhang, Yuan Guo, Yunlong Li et al. · 2019 · Cell Death and Disease
65. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
    Jianxiong Ji, Kaikai Ding, Tao Luo, Ran Xu, Xin Zhang, Bin Huang, Anjing Chen, Di Zhang, Hrvoje Miletić, Rolf Bjerkvig et al. · 2019 · Oncogene
66. A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer
    Feifan Wang, Mengjing Fan, Xuejian Zhou, Yanlan Yu, Yueshu Cai, Hongshen Wu, Yan Zhang, Jiaxin Liu, Shihan Huang, Ning He et al. · 2021 · Journal of Experimental & Clinical Cancer Research
67. YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
    Giorgia Di Benedetto, Silvia Parisi, Tommaso Russo, Fabiana Passaro · 2021 · Metabolites
68. Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer
    Amar Balihodzic, Dominik Andreas Barth, Felix Prinz, Martin Pichler · 2021 · Cancers
69. MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker
    Xiang Jin, Lihua Zhu, Sheng Xiao, Zhuhong Cui, Jing Tang, Jiangyong Yu, Mingjun Xie · 2021 · Molecular Medicine Reports
70. LncRNA GHET1 Promotes Hypoxia-Induced Glycolysis, Proliferation, and Invasion in Triple-Negative Breast Cancer Through the Hippo/YAP Signaling Pathway
    Yu Wang, Shuwei Liu · 2021 · Frontiers in Cell and Developmental Biology
71. How metformin affects various malignancies by means of microRNAs: a brief review
    Nahid Alimoradi, Negar Firouzabadi, Reihaneh Fatehi · 2021 · Cancer Cell International
72. Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
    Xiaoya Zhao, Jianfei Fu, Bin Hu, Lin Chen, Jing Wang, Jinyong Fang, Chenyang Ge, Haiping Lin, Kailing Pan, Liang Fu et al. · 2021 · Frontiers in Cell and Developmental Biology
73. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
    Dehai Wang, Zhongbo Li, Xin Li, Cheng Yan, Huijie Yang, Ting Zhuang, Xiao Wang, Yifeng Zang, Ziping Liu, Tianshi Wang et al. · 2022 · Journal of Experimental & Clinical Cancer Research
74. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.
    Zhenzhen Yan, Haihong Shi, Rongrong Zhu, Lele Li, Bai Qin, Lihua Kang, Hui Chen, Huaijin Guan · 2018 · PubMed Central
75. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation
    Akihiro Matsushita, Tatsuhiro Sato, Satomi Mukai, Teruaki Fujishita, Emi Mishiro‐Sato, Maho Okuda, Masahiro Aoki, Yoshinori Hasegawa, Yoshitaka Sekido · 2018 · Oncogene
76. Shared enhancer gene regulatory networks between wound and oncogenic programs
    Floc'hlay, Swann, Balaji, Ramya, Stanković, Dimitrije, Christiaens, Valerie M, Bravo González-Blas, Carmen, De Winter, Seppe, Hulselmans, Gert J, De Waegeneer, Maxime, Quan, Xiaojiang, Koldere, Duygu et al. · 2023 · eLife
77. Mechanical Force Directs Proliferation and Differentiation of Stem Cells
    Delin Hu, Ziqing Dong, Bin Li, Feng Lu, Ye Li · 2022 · Tissue Engineering Part B Reviews
78. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway
    Tao Li, Yujie Li · 2022 · Immunobiology
79. Low-intensity ultrasound ameliorates brain organoid integration and rescues microcephaly deficits
    Xiaohong Li, Di Guo, Li-Qun Chen, Zhe‐Han Chang, Jian-Xin Shi, Nan Hu, Chong Chen, Xiaowang Zhang, Shuang‐Qing Bao, Mengmeng Chen et al. · 2024 · Brain
80. Perspectives on the mathematics of biological patterning and morphogenesis
    Garikipati, Krishna · 2017 · Journal of the Mechanics and Physics of Solids
81. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action
    Xuan Shi, Hairong Zhu, Taotao Liu, Xizhong Shen, Ji‐Min Zhu · 2017 · Cancer Letters
82. YAP1 regulates PPARG and RXR alpha expression to affect the proliferation and differentiation of ovine preadipocyte
    Kaiping Deng, Caifang Ren, Yixuan Fan, Jing Pang, Guomin Zhang, Yanli Zhang, Peihua You, Feng Wang · 2019 · Journal of Cellular Biochemistry
83. Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma
    Didier Decaudin, Estelle Frisch-Dit-Leitz, Fariba Némati, Malcy Tarin, Adnan Naguez, Mohamed Zerara, Benjamin Marande, Raquel Vivet-Noguer, Ensar Halilovic, Claire Fabre et al. · 2020 · European Journal of Cancer
84. The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors.
    Sarah Saab, Olin Shih-Shin Chang, Kentaro Nagaoka, Mien‐Chie Hung, Hirohito Yamaguchi · 2019 · PubMed Central
85. Bone marrow mesenchymal stem cells transplantation alleviates brain injury after intracerebral hemorrhage in mice through the Hippo signaling pathway
    Xiao Chen, Canxin Xu, Huaibin Liang, Zhiyu Xi, Jiaji Pan, Yong Yang, Qingfang Sun, Guo‐Yuan Yang, Yuhao Sun, Liuguan Bian · 2020 · Aging
86. Hippo kinases MST1 and MST2 control the differentiation of the epididymal initial segment via the MEK-ERK pathway
    Chenling Meng, Geng G. Tian, Chunhua Xu, Xiaofeng Li, Yu Zhang, Yang Wang, Jinzhong Qin, Kin Lam Fok, Barry T. Hinton, Kinglun Kingston Mak et al. · 2020 · Cell Death and Differentiation
87. Targeting Hippo signaling pathway by phytochemicals in cancer therapy
    Milad Moloudizargari, Mohammad Hossein Asghari, Seyed Fazel Nabavi, Diana Gulei, Ioana Berindan‐Neagoe, Anupam Bishayee, Seyed Mohammad Nabavi · 2020 · Seminars in Cancer Biology
88. Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
    Taha Azad, Reza Rezaei, Abera Surendran, Ragunath Singaravelu, Stephen Boulton, Jaahnavi Dave, John Cameron Bell, Carolina S. Ilkow · 2020 · Cancers
89. Established and Emerging Mechanisms in the Pathogenesis of Arrhythmogenic Cardiomyopathy: A Multifaceted Disease
    Gao, Shanshan, Puthenvedu, Deepa, Lombardi, Raffaella, Chen, Suet Nee · 2020 · International Journal of Molecular Sciences
90. A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration
    Yi Wang, Yinhao Chen, Bingye Zhu, Limin Ma, Qianwei Xing · 2021 · Frontiers in Molecular Biosciences
91. Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP
    Qianqian Zhang, Wenge Li, Yanting Zhu, Qingting Wang, Cui Zhai, Wenhua Shi, Wei Feng, Jian Wang, Xin Yan, Limin Chai et al. · 2021 · Molecular and Cellular Biochemistry
92. Yap is essential for uterine decidualization through Rrm2/GSH/ROS pathway in response to Bmp2
    Hai‐Fan Yu, Zhan‐Qing Yang, Ming-Yue Xu, Ji‐Cheng Huang, Zhan‐Peng Yue, Bin Guo · 2022 · International Journal of Biological Sciences
93. AXL activates YAP through the EGFR–LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma
    Kento Okamoto, Toshinori Ando, Hiroki Izumi, Susumu S. Kobayashi, Tomoaki Shintani, Jorge Silvio Gutkind, Souichi Yanamoto, Mutsumi Miyauchi, Mikihito Kajiya · 2023 · Oncogene
94. The Hippo pathway noncanonically drives autophagy and cell survival in response to energy stress
    Gayoung Seo, Clinton Yu, Han Han, Xing Li, Rebecca Elizabeth Kattan, Jeongmin An, Amrutha Kizhedathu, Bing Yang, Annabella Luo, Abigail L. Buckle et al. · 2023 · Molecular Cell
95. CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
    Jing Wei, Guanzhen Yu, Genbao Shao, Aiqin Sun, Miao Chen, Wannian Yang, Qiong Lin · 2016 · Oncotarget
96. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma
    Jie Zhang, Liu Pin, Junyan Tao, Pan Wang, Yi Zhang, Xinhua Song, Li Che, Pavel Sumazin, Silvia Ribback, András Kiss et al. · 2019 · American Journal Of Pathology
97. Activation of the RhoA-YAP-β-catenin signaling axis promotes the expansion of inner ear progenitor cells in 3D culture
    Mingyu Xia, Yan Chen, Yingzi He, Huawei Li, Wenyan Li · 2020 · Stem Cells
98. Nitidine chloride possesses anticancer property in lung cancer cells through activating Hippo signaling pathway
    Jing Zhang, Linhui Wu, Chaoqun Lian, Shuo Lian, Shimeng Bao, Jisheng Zhang, Z. Peter Wang, Jia Ma, Yuyun Li · 2020 · Cell Death Discovery
99. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein
    Yang, Siyuan, Xu, Weizhi, Liu, Cheng, Jin, Jiaqi, Li, Xueying, Jiang, Yuhan, Zhang, Lei, Meng, Xianbin, Zhan, Jun, Zhang, Hongquan · 2022 · Science China Life Sciences
100. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village
     Yong-Qiang Ao, Jian Gao, Jia-Hao Jiang, Haikun Wang, Shuai Wang, Jian‐Yong Ding · 2023 · Molecular Therapy